ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Patient-perceived barriers and facilitators for risk-stratified follow-up care in lung cancer: a qualitative study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Healthcare professionals' perceived barriers and facilitators of risk-stratified follow-up care in lung cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe shortage of healthcare professionals alongside the rising number of lung cancer survivors poses a significant challenge to current healthcare facilities. Risk-stratified follow-up care, with tailored diagnostic imaging and follow-up intervals based on a patients' risk of recurrence, may improve clinical outcomes and help address this challenge. Our study is aimed at identifying patient-perceived barriers and facilitators for implementing this approach.
methodsA qualitative study was performed including 15 semi-structured interviews and three focus groups (n = 16) among lung cancer patients who completed treatment and currently receive follow-up care. Inductive and axial coding of the transcripts was performed to categorize codes into barriers and facilitators at six different levels using the Grol and Wensing framework.
resultsMost barriers were identified at the organizational, economic, and political levels when shortening follow-up intervals and altering the imaging modalities due to limited available personnel, restricted imaging logistics, and financial resources. At the patient level, the most important barrier is fear of recurrence when extending follow-up intervals. Facilitators at the organizational level involved providing a direct point of contact and supportive care during risk-stratified follow-up. Overall, patients are willing to adopt risk-stratified follow-up care when sufficient evidence for its effectiveness is provided.
conclusionWe found most of the barriers, facilitators, and preferences at the organizational, economic, political, and patient level. The identified barriers and facilitators in this study can serve as a base for a strategy to implement a risk-stratified follow-up care in lung cancer care if effectiveness can be proven.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.